Cognitive deficits in rats exposed to methylazoxymethanol (MAM) on gestational day 17; A preclinical model of schizophrenia

被引：0
|
作者：
Flagstad, P [1 ]
Glenthoj, B [1 ]
Didriksen, M [1 ]
机构：
[1] Copenhagen Univ Hosp, Bispebjerg, Denmark
来源：
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY | 2004年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S435 / S436
页数：2
相关论文
共 50 条
  • [1] Cognitive deficits caused by late gestational disruption of neurogenesis in rats: A preclinical model of schizophrenia
    Flagstad, P
    Glenthoj, BY
    Didriksen, M
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 (02) : 250 - 260
  • [2] Cognitive Deficits Caused by Late Gestational Disruption of Neurogenesis in Rats: a Preclinical Model of Schizophrenia
    Peter Flagstad
    Birte Y Glenthøj
    Michael Didriksen
    Neuropsychopharmacology, 2005, 30 : 250 - 260
  • [3] Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats
    Ruda-Kucerova, Jana
    Babinska, Zuzana
    Amchova, Petra
    Stark, Tibor
    Drago, Filippo
    Sulcova, Alexandra
    Micale, Vincenzo
    WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2017, 18 (02): : 129 - 142
  • [4] Memory deficits with intact cognitive control in the methylazoxymethanol acetate (MAM) exposure model of neurodevelopmental insult
    O'Reilly, Kally C.
    Perica, Maria I.
    Fenton, Andre A.
    NEUROBIOLOGY OF LEARNING AND MEMORY, 2016, 134 : 294 - 303
  • [5] Prenatal methylazoxymethanol treatment in the rat: A neurodevelopmental model for studying cognitive deficits in schizophrenia?
    Gourevitch, R
    Jay, TM
    Le Pen, G
    Rocher, C
    Krebs, MO
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 57 - 57
  • [6] Alterations in prefrontal glutamatergic and noradrenergic systems following MK-801 administration in rats prenatally exposed to methylazoxymethanol at gestational day 17
    Isabelle Léna
    Aline Chessel
    Gwenaëlle Le Pen
    Marie-Odile Krebs
    René Garcia
    Psychopharmacology, 2007, 192 : 373 - 383
  • [7] Cognitive performance of the MAM-E17 schizophrenia model rats in different age-periods
    Kallai, Veronika
    Lenard, Laszlo
    Peczely, Laszlo
    Galosi, Rita
    Dusa, Daniella
    Toth, Attila
    Laszlo, Kristof
    Kertes, Erika
    Kovacs, Anita
    Zagoracz, Olga
    Berta, Beata
    Karadi, Zoltan
    Ollmann, Tamas
    BEHAVIOURAL BRAIN RESEARCH, 2020, 379
  • [8] Alterations in prefrontal glutamatergic and noradrenergic systems following MK-801 administration in rats prenatally exposed to methylazoxymethanol at gestational day 17
    Lena, Isabelle
    Chessel, Aline
    Le Pen, Gwenaelle
    Krebs, Marie-Odile
    Garcia, Rene
    PSYCHOPHARMACOLOGY, 2007, 192 (03) : 373 - 383
  • [9] Epigenetic regulation in the dorsal hippocampus of rats exposed to methylazoxymethanol acetate; a model of schizophrenia
    Khan, A. Q.
    Jahn, K.
    Thielen, L.
    Kebir, O.
    Pen, G. L.
    Jay, T. M.
    Krebs, M. O.
    Frieling, H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S381 - S382
  • [10] Abnormal reward processing in the methylazoxymethanol (MAM) model of schizophrenia: neural and behavioural evidence
    Francois, J.
    Conway, M.
    Huxter, J.
    Lowry, J. P.
    Tricklebank, M.
    Gilmour, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S282 - S283
12345